Individual dendritic cell (DC) lineages have non-redundant roles in defense against pathogens 1 . Plasmacytoid DCs (pDCs) produce type I interferons to limit viral infection 2 but are limited in presenting antigen to T cells 3 . The two conventional DC (cDC) lineages, represented by splenic CD8α + DCs and CD4 + DCs 4 , selectively express the transcription factors IRF8 or IRF4, respectively 5, 6 . IRF8 + cDCs function in vivo in cross-presentation to CD8 + T cells and in the induction of interleukin 12-dependent responses of the T H 1 subset of helper T cells 7, 8 , while IRF4 + cDCs function in promoting immune responses by T H 17 and T H 2 cells [9] [10] [11] . Both in vivo and in bone marrow (BM) cultures treated with the cytokine Flt3L, IRF8 + cDCs can be identified as CD24 + CD172a − cells (called 'CD24 + DCs' here) and IRF4 + cDCs can be identified as CD24 − CD172a + cells (called 'CD172a + cDCs' here).
Individual dendritic cell (DC) lineages have non-redundant roles in defense against pathogens 1 . Plasmacytoid DCs (pDCs) produce type I interferons to limit viral infection 2 but are limited in presenting antigen to T cells 3 . The two conventional DC (cDC) lineages, represented by splenic CD8α + DCs and CD4 + DCs 4 , selectively express the transcription factors IRF8 or IRF4, respectively 5, 6 . IRF8 + cDCs function in vivo in cross-presentation to CD8 + T cells and in the induction of interleukin 12-dependent responses of the T H 1 subset of helper T cells 7, 8 , while IRF4 + cDCs function in promoting immune responses by T H 17 and T H 2 cells [9] [10] [11] . Both in vivo and in bone marrow (BM) cultures treated with the cytokine Flt3L, IRF8 + cDCs can be identified as CD24 + CD172a − cells (called 'CD24 + DCs' here) and IRF4 + cDCs can be identified as CD24 − CD172a + cells (called 'CD172a + cDCs' here).
Several transcription factors control the development of DCs from the BM-resident common DC progenitor (CDP) [12] [13] [14] . IRF8 is expressed by and required for the development of both pDCs and CD24 + DCs 6, [15] [16] [17] . IRF8 reportedly binds to the promoter of its own gene Irf8 in a macrophage cell line 18 and may be regulated by a positive autoregulatory loop in pDCs 19 . In contrast, IRF4 is required in the CD172a + DC lineage 20 . The basic helix-loop-helix transcription factor E2-2 is expressed by pDCs and is required for their development 3, 21 , while Id2, an inhibitor of basic helix-loop-helix transcription factors, is expressed by both cDC subsets but is required only for the development of CD24 + cDCs [22] [23] [24] .
Heterodimers of the transcription factors Batf3 and Jun interact with IRFs to stabilize binding of a heterocomplex to transcription factor AP1-IRF composite elements (AICEs) 25, 26 . Both Batf and Batf3 can interact with both IRF4 and IRF8, but Batf is expressed neither in mature DCs nor in progenitors of DCs during development at homeostasis 25 . Like Id2, Batf3 is expressed in both CD24 + DCs and CD172a + DCs, but Batf3 is required only for the development of CD24 + cDCs, both for splenic CD24 + cDCs and for peripheral tissue-resident and migratory CD103 + cDCs of the CD24 + DC lineage 7, 27 .
Batf3 −/− mice exhibit severe functional immunological impairment 7, 8, 28 . However, there is an unexplained residual population of CD24 + cDCs in Batf3 −/− mice 25 . Therefore, it is possible that Batf3 may control gene expression only in mature CD24 + cDCs instead of controlling the development of this lineage, similar to the respective actions of the transcription factors EBF and Pax5 in B cell development 29 . If so, residual CD24 + cDCs in Batf3 −/− mice might represent cells undergoing abnormal development.
Here we present a model to explain the role of Batf3 in CD24 + cDC development. First, we identified clonogenic progenitors that arose directly from the CDP that were committed to becoming either CD24 + cDCs or CD172a + cDCs. We found that the clonogenic progenitor of CD24 + cDCs, the pre-CD8 DC, could be specified without Batf3 but that Batf3 was necessary at this stage to sustain autoactivation of Irf8 through an enhancer element that was active exclusively in CD24 + cDCs. In Batf3 −/− mice, this progenitor failed to commit to the CD24 + cDC lineage because of the decay of Irf8 autoactivation and diverted into the IRF4 + CD172a + lineage.
RESULTS

Autoactivation of Irf8 in early progenitor cells
We first confirmed the lack of CD24 + cDCs in Irf8 −/− mice 6 and BXH2 mice 17 , which are homozygous for a mutation in Irf8 that results in a substitution (R294C) that prevents the interaction of IRF8 with partner transcription factors PU.1, IRF2 and SpiB 17 (Fig. 1a) . Unexpectedly, heterozygous Irf8 +/− mice had a fivefold lower frequency of CD24 + cDCs than that of wild-type mice, with a lower mean fluorescence intensity (MFI) of CD24 (Fig. 1a) , and a similarly lower abundance CD8α + CD205 + cells (Supplementary Fig. 1a ). These decreases were greater than would be predicted from half the amount of IRF8 protein in heterozygous mice. Similarly, there was 77% lower frequency of CD24 + cDCs in Irf8 +/− BM than in wild-type BM and 95% fewer CD103 + cells derived from culture of BM with Flt3L (Fig. 1b) . The phenotype of Irf8 +/− mice for the development of CD24 + cDC was consistent with transcriptional Irf8 autoactivation [30] [31] [32] , in which IRF8 regulates its own transcription 19 .
To find the developmental stage at which autoactivation of Irf8 occurs, we examined the expression of IRF8 protein in macrophage and DC progenitors (MDPs) 33 and CDPs 13, 14 . IRF8 expression was lower in wild-type MDPs than in wild-type CDPs (Fig. 1c,d ), similar to results obtained for a published IRF8-EGFP reporter mouse 34 , and was only slightly lower in Irf8 +/− MDPs than in wild-type MDPs (Fig. 1c,d ). IRF8 levels increased in wild-type cells during the transition from MDP to CDP, but a smaller increase occurred for Irf8 +/− CDPs (Fig. 1d) . CDPs from BXH2 mice also had lower expression of IRF8 than that of wild-type CDPs (Fig. 1d) . These results suggested that the autoactivation of Irf8 occurred as early as the CDP stage and required the interaction of IRF8 with a partner such as PU.1.
We expressed IRF8 via retrovirus in the progenitors of DCs to test that hypothesis. Retrovirally expressed IRF8 increased the development of CD24 + cDCs to 51% of total cDCs from Irf8 +/− BM, compared with about 8% for Irf8 +/− samples transduced with control (empty) retrovirus, whereas in Irf8 −/− BM, CD24 + cDCs increased to only 14% of total cDCs (Fig. 1e) . This suggested that efficient reconstitution by retrovirally expressed IRF8 required an intact endogenous Irf8 locus. Moreover, retroviral expression of the mutant IRF8(R294C) increased CD24 + cDC development only twofold in Irf8 +/− BM, relative to the development in cells transduced with control (empty) retrovirus , but not at all in Irf8 −/− BM (Fig. 1e) , which suggested that the inability of IRF8(R294C) to activate its own expression might have caused, in part, the observed defect in CD24 + cDCs in BXH2 mice, similar to that of Irf8 −/− mice 5, 6 . WT Irf8 
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A r t i c l e s
We next investigated whether retrovirally expressed IRF8 would be able to induce the expression of endogenous IRF8 protein. Flt3L-treated wild-type BM cells infected with empty retrovirus included two distinct cDC populations with endogenous IRF8 expression that was either low (49%) or high (35%), while heterozygous Irf8 +/− BM included predominantly cDCs with low endogenous IRF8 expression (64%) (Fig. 1f) . Retroviral expression of IRF8 resulted in low IRF8 expression in 73% of infected Irf8 −/− cDCs, but it substantially increased the percentage of cells with high total expression of IRF8 (retroviral and endogenous) relative to that of cells infected with control (empty) retrovirus, for Irf8 +/− cDCs (from 4.8% to 51%) and wild-type cDCs (from 35% to 73%) (Fig. 1f) . Thus, the increase in total IRF8 protein induced by retrovirally expressed IRF8 in Irf8 +/− cDCs relative to that in Irf8 −/− cDCs occurred because of autoactivation at the endogenous Irf8 locus.
Analysis of the binding of IRF8 to the Irf8 locus by chromatin immunoprecipitation followed by sequencing (ChIP-seq) showed several peaks for the binding of IRF8, located upstream and downstream of the Irf8 coding region but not at the Irf8 promoter (Fig. 1g) . As a negative control, we observed no peaks for the binding of IRF8 in DCs derived from Irf8 −/− BM. The binding of IRF8 to regulatory elements within the Irf8 locus was consistent with autoactivation of Irf8.
Batf3 maintains IRF8 in CD24 + cDCs Direct interaction between the Batf3 leucine zipper and IRF8 is required for the development of CD24 + cDCs 25 . Since IRF8 expression in CDPs involved an interaction between IRF8 and PU.1, we sought to determine if IRF8 expression in mature CD24 + cDCs might also involve Batf3. Irf8 −/− mice showed a complete lack of CD24 + cDCs, but Batf3 −/− mice had a CD24 + cDC population that was approximately 82% smaller than that of wild-type mice (Fig. 2a) . Although certain infections can increase the frequency of CD24 + cDCs in Batf3 −/− mice due to compensation by Batf2 or Batf 25 , the persistence of these cells in uninfected Batf3 −/− mice has never been explained.
Wild-type CD24 + cDCs had high expression of IRF8; however, the residual Batf3 −/− CD24 + cDCs had heterogeneous and lower IRF8 expression relative to that of wild-type CD24 + cDCs (Fig. 2b) . In contrast, pDCs had abundant expression of IRF8, and CD172a + cDCs had much lower expression of IRF8 in wild-type and Batf3 −/− mice than did their CD24 + counterparts (Fig. 2b) . Thus, residual CD24 + cDCs in Batf3 −/− mice were abnormal, with heterogeneous expression of IRF8; this suggested a possible role for Batf3 in directly regulating IRF8 expression in this lineage.
cDC divergence occurs in the BM CD24 + cDCs and CD172a + cDCs share a common progenitor called the 'pre-cDC' , originally defined as lineage marker-negative (Lin − ) CD135 + MHCII − CD11c + cells that develop from CDPs 35 . Since pre-cDCs had heterogeneous expression of the cytokine receptor CD115 (MCSF-R) ( Supplementary Fig. 1b) , we sought to determine if CD115 expression could be used to distinguish pre-cDCs that were committed to the CD24 + cDC lineage or the CD172a + cDC lineage. As a control, we found that CDPs generated CD24 + and CD172a + cDCs and pDCs, but the CD115 + fraction of pre-cDCs developed exclusively into CD172a + cDCs ( Supplementary Fig. 1c,d ). In contrast, the CD115 − fraction of pre-cDCs developed into both pDCs and CD172a + cDCs ( Supplementary Fig. 1c,d ), consistent with a published report showing that Lin − CD11c − CD135 + CD115 − CD117 int-lo BM is enriched for progenitors of pDCs 36 . However, CD115 − pre-cDCs did not develop into CD24 + cDCs ( Supplementary Fig. 1c,d) . Thus, unexpectedly, neither fraction of the originally defined pre-cDCs generated CD24 + cDCs.
To identify the source of CD24 + cDCs, we used Zbtb46 GFP/+ mice, in which expression of green fluorescent protein (GFP) from the locus encoding the transcription factor Zbtb46 identifies BM progenitors exclusively committed to cDC lineages and not pDCs or their progenitors 37 . Although pre-cDCs were originally defined as MHCII − cells 35 , we noticed that strict exclusion of MHCII int cells from the CD11c + pre-cDC gate identified cells that were CD117 − and had heterogeneous Zbtb46-GFP expression (Fig. 3a) . By including MHCII int cells in the CD11c + pre-cDC gate, we identified an additional population of CD117 int Zbtb46-GFP + cells (Fig. 3a) that were largely negative for CD115 expression (data not shown) and would have been excluded by the strict lineage gate used ( Supplementary  Fig. 1b) . Therefore, we sought to determine if these MHCII int precDCs might generate CD24 + cDCs. Indeed, these CD117 int MHCII int Zbtb46-GFP + pre-cDCs developed exclusively into CD24 + cDCs but did not develop into CD172a + cDCs or pDCs (Fig. 3b) . In contrast, the CD115 + CD117 − MHCII − fraction of pre-cDCs developed exclusively into CD172a + cDCs ( Fig. 3b and Supplementary Fig. 1c,d) . Thus, commitment to distinct branches of cDCs occurred in the BM and yielded progenitors that we call 'pre-CD8 DCs' (defined as (Fig. 3b) .
Pre-CD8 DCs arise directly from CDPs
To determine if pre-CD8 DCs develop directly from CDPs, we monitored purified Zbtb46 GFP/+ CDPs cultured with Flt3L. CDPs rapidly acquired expression of CD11c, Zbtb46-GFP and major histocompatibility complex class II (MHCII) and diverged into two distinct populations distinguished by CD117 expression (Supplementary Fig. 2 ).
One population retained intermediate CD117 expression, becoming CD117 int CD11c + MHCII int Zbtb46-GFP + cells, similar to pre-CD8 DCs (Supplementary Fig. 2b) . The second population lost CD117 expression and resembled pre-CD4 DCs (CD117 − CD11c + MHCII − Zbtb46-GFP + cells) (Supplementary Fig. 2b ). The pre-CD8 DCs and pre-CD4 DCs had the morphology of immature progenitors similar to CDPs, with the large nuclei, scant cytoplasm and lack of dendrites shown by mature CD24 + cDCs (Fig. 3c) . Pre-cDCs have been shown to be identifiable in both blood and spleen 35, 38 . In agreement with that, we found in both blood and spleen a CD117 int MHCII int Zbtb46-GFP + population that resembled pre-CD8 DCs (Fig. 3d) . We next investigated the transcription factor requirements for the specification of CDPs to pre-CD8 DCs. Zbtb46-GFP + pre-CD8 DCs from Batf3 −/− Zbtb46 GFP/+ and Irf4 −/− Zbtb46 GFP/+ mice were present in frequencies similar to those of Batf3 +/+ Zbtb46 GFP/+ mice and Irf4 +/+ Zbtb46 GFP/+ mice but were absent in Irf8 −/− Zbtb46 GFP/+ mice (Fig. 4a) . Some splenic pre-cDCs that express CD24 have been described as being largely committed to develop into CD8α + cDCs 38 . We found that CD24 expression was restricted to the Zbtb46-GFP + CD117 int pre-CD8 DC fraction (Fig. 4a,b) . We investigated whether CD24 expression could replace Zbtb46-GFP expression in the identification of pre-CD8 DCs. Pre-CD8 cDCs identified by CD24 expression committed exclusively to development into CD24 + cDCs and required IRF8, but not Batf3 or IRF4, to develop, similar to those identified by Zbtb46-GFP expression (Fig. 4b,c) . In summary, we identified separate clonogenic progenitors for CD24 + cDC and CD172a + cDC lineages that arose directly from CDPs. Pre-CD8 DCs developed in Batf3 −/− mice but not in Irf8 −/− mice and were detectable in blood and in spleen. (Fig. 5a) . Pre-CD8 DCs and CD24 + cDCs clustered together and segregated from pre-CD4 DCs and CD172a + cDCs along PC2 and PC3, which accounted for nearly all of the remaining variation (Fig. 5a,b) . In pairwise comparisons, the expression of some genes changed at different stages during the development of CD24 + cDCs and that of CD172a + cDCs, including some genes with equal expression in both mature cDC subsets (Fig. 5c,d ). For example, H2-Aa (which encodes an isotype of MHC class II) was fully induced during the transition from CDP to pre-CD8 DC but was induced only to an intermediate amount in pre-CD4 DCs (Fig. 5c,d ). In contrast, the genes encoding myeloperoxidase (Mpo) and cathepsin G (Ctsg) were fully downregulated during the CDP-to-pre-CD4 DC transition but decreased to an intermediate extent in pre-CD8 DCs (Fig. 5c,d) . Hierarchical clustering further showed that pre-CD8 DCs and pre-CD4 DCs were distinct from CDPs and each other (Fig. 5e) as well as from mature cDC subsets (Fig. 5f) .
Many transcription factor-encoding genes (Fig. 5g,h ) and cell surface marker-encoding genes (Fig. 5i) showed stage-specific regulation. For example, Batf3 and Id2 were upregulated during the CDP-to-pre-CD8 DC transition to the expression found in mature CD24 + cDCs, but their upregulation was delayed during the development of CD172a + cDCs (Fig. 5g,h) . In contrast, Nr4a1 (which encodes Nur77), Nr4a2 and Nr4a3 were upregulated during the transition from pre-CD8 DC to mature CD24 + cDC (Fig. 5g) . Notably, Irf8 was still expressed in pre-CD4 DCs and was not downregulated until the mature CD172a + cDC stage (Fig. 5h) . In contrast, Irf4 did not have high expression in pre-CD4 DCs but instead had high expression only in mature CD172a + cDCs (Fig. 5h) . Because we used Zbtb46 GFP/+ cells to identify pre-CD8 DCs and pre-CD4 DCs, Zbtb46 transcripts increased in abundance modestly during the CDP-to-pre-CD8 DC transition and CDP-to-pre-CD4 DC transition (Fig. 5h) . Together these data suggested that pre-CD4 DCs and pre-CD8 DCs represent discrete stages of development.
Control of Irf8 expression by a Batf3-dependent enhancer
We sought evidence of a direct role for Batf3 in regulating Irf8 expression. For this, we performed ChIP-seq analysis of IRF8 in CD24 + cDCs and pDCs, which had high expression of IRF8, and of Batf3 in CD24 + cDCs and CD172a + cDCs, which expressed Batf3 ( Supplementary  Fig. 3a,b) . In CD24 + cDCs, the binding of Batf3 and that of IRF8 were localized together at sites −26 kilobases (kb) and +32 kb from the Irf8 transcriptional start site (TSS) (Fig. 6a) . IRF8 also bound at sites −16 kb and +41 kb from the Irf8 TSS in both CD24 + cDCs and pDCs, but Batf3 did not (Fig. 6a) . In CD24 + cDCs and pDCs, we observed binding of the histone acetyltransferase p300, indicative of enhancer activity, at both the element +32 kb from the Irf8 TSS and the element +41 kb from the Irf8 TSS (Fig. 6a) . In CD172a + cDCs, which expressed IRF4, the Irf8 locus lacked binding of p300 and Batf3 (Fig. 6a) , which suggested that the Batf3-IRF8 heterodimers, rather than Batf3-IRF4 heterodimers, might bind 'preferentially' to this locus.
Large, high-density clusters that bind master transcription factors, have unusually high levels of mediator binding, or have active histone marks, called 'superenhancers' , have been recognized as being critical in controlling cell identity 39, 40 . The Irf8 locus showed acetylation of histone H3 at Lys27 (H3K27ac) and monomethylation of histone H3 at Lys4 (H3K4me1) throughout a 60-kb region in CD24 + cDCs and pDCs and showed binding of H3K4me1 but no binding of H3K27ac in CD172a + cDCs (Fig. 6a) . Thus, the Irf8 locus was poised but not active in CD172a + cDCs. The Irf8 peaks at +32 kb and +41 kb from the Irf8 TSS showed depletion for the binding of H3K4me1 and H2K27ac in CD24 + cDCs (Supplementary Fig. 3c ). The Irf8 locus was the topranked superenhancer region in CD24 + cDC and pDCs, as assessed through use of the normalized H3K27ac ChIP-seq signal, but did not rank as a superenhancer in CD172a + cDCs ( Supplementary  Fig. 4a-c) . We were able to identify superenhancers with distinct DC specificity. For example, a superenhancer at the Itgae locus (which encodes the integrin α E ) was specific for CD24 + cDCs, and a superenhancer for the Bcl11a locus (which encodes the transcriptional npg regulator Bcl-11A) was specific for pDCs ( Supplementary Fig. 4d ).
The Id2 locus had superenhancer activity in both CD24 + cDCs and CD172a + cDCs (Supplementary Fig. 4d ). In summary, the region +32 kb from the Irf8 TSS bound Batf3, IRF8 and p300 and was within an Irf8 superenhancer.
We assessed the activity of several of the genomic regions described above, through the use of retroviral reporters in DCs derived from culture with Flt3L [41] [42] [43] . The Irf8 minimal promoter, either alone or in cis with the region −26 kb from the Irf8 TSS, was inactive in all DC subsets (Fig. 6b and Supplementary Fig. 5a-d) . The element −16 kb from the Irf8 TSS and a previously identified PU.1-binding element at −50 kb from the Irf8 TSS 44 were generally active in all DC subsets, remained active in Batf3 −/− pDCs and had slightly more activity in Batf3 −/− CD172a + cDCs than in wild-type CD172a + cDCs (Supplementary Fig. 5b,c) , perhaps reflective of an original commitment of some of these cells to the CD24 + lineage. In contrast, the element +32 kb from the Irf8 TSS was active specifically in CD24 + cDCs but not in CD172a + cDCs or pDCs and was less active in the few remaining Batf3 −/− CD24 + cDCs than in wild-type CD24 + cDCs ( Fig. 6b and Supplementary Fig. 5a-c) . Conversely, the element +41 kb from the Irf8 TSS was active specifically in pDCs, not in CD24 + DCs, and remained active in Batf3 −/− pDCs ( Fig. 6b  and Supplementary Fig. 5a-c) . Through the use of de novo motif discovery, we identified AICE motifs in Batf3-binding peaks (Supplementary Fig. 6a ) that were present four times within the element +32 kb from the Irf8 TSS 25, 26 (Supplementary Fig. 6b-e) . Of the four AICE motifs in the element +32 kb from the Irf8 TSS, AICE sites 1 and 2 were the most highly conserved between mouse and human ( Supplementary Fig. 6d,e) . Thus, Batf3-dependent autoactivation of Irf8 in CD24 + cDCs may operate at an element +32 kb from the Irf8 TSS, within an Irf8 superenhancer.
IRF8 expression becomes dependent on Batf3
Next we sought to determine which stage of CD24 + cDC development required Batf3. Pre-CD8 DCs appeared at a similar frequency in the BM of Batf3 −/− mice and wild-type mice (Fig. 7a) but were about 40% lower in frequency in the blood and spleen of Batf3 −/− mice than in that of wild-type mice (Fig. 7a,b) . The amount of IRF8 protein was similar in Batf3 −/− BM pre-CD8 DCs and wild-type BM pre-CD8 DCs (Fig. 7c,d) . However, Batf3 −/− pre-CD8 DCs in blood and spleen had lower levels of IRF8 than that of their wild-type counterparts (Fig. 7c,d) . 
A r t i c l e s
To determine the eventual fate of pre-CD8 DCs in Batf3 −/− mice, we monitored the differentiation of wild-type and Batf3 −/− CDPs, pre-CD8 DCs and pre-CD4 DCs over 5 d of culture with Flt3L. As expected, wild-type CDPs produced both CD24 + and CD172a + cDCs, and wild-type and Batf3 −/− pre-CD4 DCs produced exclusively CD172a + DCs (Fig. 7e,f) . Wild-type and Batf3 −/− pre-CD8 DCs initially expressed CD24 in the BM (Fig. 4b) , but Batf3 −/− pre-CD8 DCs progressively downregulated CD24 expression and gained CD172a expression (Fig. 7e,f) . Batf3 −/− pre-CD8 DCs initially had abundant IRF8 expression, but this rapidly decreased to the amount expressed by wild-type CD172a + DCs (Fig. 7g,h) .
Similarly, wild-type BM pre-CD4 DCs had heterogeneous IRF8 expression, with 38% exhibiting high IRF8 expression (Supplementary Fig. 7a ), in agreement with the abundant transcription of Irf8 in pre-CD4 DCs (Fig. 5h) . However, IRF8 expression was lost by day 1 during culture of pre-CD4 DCs with Flt3L ( Supplementary  Fig. 7b) . The low Batf3 expression by pre-CD4 DCs (Fig. 5h) and the instability of IRF8 expression in pre-CD4 DCs were consistent with a requirement for Batf3 in maintaining IRF8 expression in cDCs. In summary, these results suggested that pre-CD8 DCs were specified normally in Batf3 −/− mice but converted to the CD172a + cDC lineage because they failed to maintain IRF8 expression.
Transgenic IRF8 overexpression bypasses Batf3 dependence
The transgenic Irf8 VENUS reporter carries three copies of a phage artificial chromosome containing a 130-kb Irf8 genomic region harboring a cassette containing an internal ribosome entry site and sequence encoding the yellow fluorescent protein VENUS within the Irf8 3′ untranslated region 44 ; this results in five Irf8 loci that each contain all of the recognized regulatory elements. VENUS expression reproduces the expected IRF8 expression in mature wild-type DC subsets 44 but has not been examined in Batf3 −/− mice. Batf3 +/+ Irf8 VENUS+ mice developed splenic DC subsets normally, although CD24 + cDCs in those mice showed slightly higher expression of CD24 than that of CD24 + cDCs in wild-type (Batf3 +/ + Irf8 VENUS− ) mice (Fig. 8a) , and Batf3 +/+ Irf8 VENUS+ mice showed high VENUS expression in CD24 + cDCs and pDCs and low VENUS expression in CD172a + cDCs (Supplementary Fig. 8) . Thus, the development of wild-type CD24 + cDCs was not affected by increased IRF8. Unexpectedly, Batf3 −/− Irf8 VENUS+ mice showed normal splenic CD24 + cDC development, whereas Batf3 −/− Irf8 VENUS− mice had diminished splenic CD24 + cDC development, as expected (Fig. 8a) . The residual CD24 + cDCs in Batf3 −/− mice had lower IRF8 expression than did those from wild-type mice, as before (Fig. 2b) ; however, CD24 + cDCs in Batf3 −/− Irf8 VENUS+ mice maintained their IRF8 expression (Fig. 8b,c) . These results showed that higher expression of IRF8 protein in Batf3 −/− Irf8 VENUS+ mice bypassed the requirement for Batf3 in the autoactivation of Irf8. These actions of Irf8 VENUS on pre-CD8 DCs were apparent in BM as well. MHCII int BM pre-CD8 DCs matured normally into MHCII hi IRF8 + cDCs (Fig. 8d) . In contrast, Batf3 −/− pre-CD8 DCs lost IRF8 as they matured and acquired expression of MHC class II (Fig. 8d) . However, this loss of IRF8 was reversed in Batf3 −/− Irf8 VENUS+ mice (Fig. 8e,f) . In summary, the usual 
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A r t i c l e s requirement for Batf3 in the autoactivation of Irf8 could be bypassed by increasing the number of copies of endogenous Irf8 loci.
DISCUSSION
Our study has extended the understanding of DC development by identifying committed clonogenic precursors of CD24 + cDCs and CD172a + cDCs, which represent the CD8α + cDC lineage and CD4 + cDC lineage, respectively. These findings were made possible by the use of Zbtb46 GFP reporter mice, in which Zbtb46-GFP + BM progenitors are committed to cDC fates and exclude pDC potential 37 . In published articles, pre-cDC populations were not defined on the basis of CD117 expression 35 but contained both CD117 int cells and CD117 neg cells. We showed that CD117 expression among Zbtb46-GFP + pre-cDCs could be used to distinguish clonogenic progenitors of CD8α + cDCs and CD4 + cDCs that were CD117 int and CD117 − , respectively. The CD117 − fraction of pre-cDCs lacked the potential to develop into CD24 + DCs; however, it had heterogeneous expression of CD115. While CD117 − CD115 + pre-cDCs were mostly Zbtb46-GFP + and developed exclusively into CD172a + cDCs, CD117 − CD115 − pre-cDCs were mostly Zbtb46-GFP − and retained potential to develop into either pDCs or CD172a + cDCs, consistent with a report indicating a bias of CD115 − progenitors toward the pDC fate 36 . An exclusive progenitor of pDCs has not been defined 45 .
Transcriptional autoactivation circuits can stabilize lineage-fate 'decisions' 30 . As an example, autoactivation of the gene encoding the transcription factor GATA-3 stabilizes the development of T H 2 cells 31 . Autoactivation of Irf8 has been suggested before 19, 34 but has not been examined during DC development, to our knowledge. A published study has shown that a PU.1-dependent enhancer at −50 kb from the Irf8 TSS initially drives Irf8 expression in MDPs 44 . We found that the increase in IRF8 expression in CDPs was sensitive to the R294C substitution of IRF8 that influences the interaction of IRF8 with PU.1 as well as with IRF2 and SpiB 17, 46, 47 . This extends the role of PU.1 to also include the autoactivation of Irf8 in early BM progenitors.
We found that commitment, but not specification, to the CD24 + cDC lineage was Batf3 dependent. Batf3 expression was induced during specification in wild-type pre-CD8 DCs, along with Id2 expression, and Batf3 was needed to sustain autoactivation of Irf8. Without Batf3, IRF8 expression decayed in the progeny of pre-CD8 DCs, which then did not commit to the CD24 + cDC lineage but diverted toward the CD172a + cDC lineage. Further studies are needed to determine the transcription factors involved in the specification of pre-CD8 and pre-CD4 DCs.
The normal loss of IRF8 in the CD172a + DC lineage could also be explained as a lack of Batf3-dependent autoactivation of Irf8. The pre-CD4 DCs had heterogeneous expression of IRF8 but did not yet express Batf3. This indicated that commitment to CD172a + cDCs occurred before complete loss of IRF8 and suggested that Irf8 transcription decayed at this stage, as in Batf3 −/− pre-CD8 DCs, because of the lack of Batf3. Thus, the delay in Batf3 expression, and possibly in Id2 expression, in pre-CD4 DCs relative to that in pre-CD8 DCs might explain the differential IRF8 expression in the lineages. Conceivably, the E3 ligase Cbl, which can promote degradation of IRF8 protein 48 , might regulate differential IRF8 expression; however, since Cbl is uniformly expressed across all stages, this seems unlikely. Competition with IRF4 is also a possible mechanism. However, IRF4 did not have abundant expression in pre-CD4 cDCs.
Notably, while CD24 + cDCs required Batf3 for sustained Irf8 expression, pDCs did not. The Irf8 locus has the characteristics of a superenhancer in both CD24 + cDCs and pDCs 39, 40 but uses different enhancer elements in those two lineages. An element +32 kb from the Irf8 TSS bound IRF8, Batf3 and p300 and had enhancer activity exclusively in CD24 + cDCs, while an element +41 kb from the Irf8 TSS bound IRF8 and p300, but not Batf3, and functioned in pDCs.
Batf and Batf2 can compensate for Batf3 in CD24 + cDC development during infection 25 . However, this does not explain residual CD8α + CD103 + cDCs observed in uninfected Batf3 −/− mice 7 , which nonetheless are impaired in several pathogen models in vivo 7, 8, 28, 49 . Here we found that the residual CD24 + cDCs in Batf3 −/− mice had heterogeneous IRF8 expression as it underwent transcriptional decay and were probably non-functional. The maintenance of IRF8 expression in Batf3 −/− mice restored splenic CD24 + cDC development, but whether all the functions of cells are restored, as well as whether they depend on Batf3, will require further study.
METHODS
Methods and any associated references are available in the online version of the paper.
